← Open Payments lookup

KASEY KEENE: Open Payments

NPI 1013332246 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,335 in 73 payments from 17 companies in 2025. Trend: 2023 $739 · 2024 $915 · 2025 $1,335

Food & beverage: $1,335
CompanyPaymentsAmount
Janssen Biotech, Inc.16$340
Sumitomo Pharma America, Inc.21$192
Dendreon Pharmaceuticals LLC5$158
Astellas Pharma US Inc9$139
Bayer Healthcare Pharmaceuticals Inc.5$110
IMMUNITYBIO, INC.2$65
ABBVIE INC.2$49
Olympus America Inc.2$41
ACCORD HEALTHCARE, INC.2$39
Merck Sharp & Dohme LLC1$34

Products named: ERLEADA, PROVENGE, Xtandi, GEMTESA, Nubeqa, ORGOVYX, ANKTIVA, BOTOX.

Industry payments across TX — which companies pay providers there.